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Abstract
Background: Pulmonary embolism (PE) is a common and potentially fatal disease that is still underdiagnosed. The objective
of our study was to reappraise the clinical presentation of PE with emphasis on the identification of the symptoms and signs
that prompt the patients to seek medical attention.
Methodology/Principal Findings: We studied 800 patients with PE from two different clinical settings: 440 were recruited in
Pisa (Italy) as part of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis (PISAPED); 360 were
diagnosedwithandtreatedforPEinsevenhospitalsofcentralTuscany,andevaluatedattheAtherothromboticDisordersUnit,
Firenze (Italy), shortly after hospital discharge. We interviewed the patients directly using a standardized, self-administered
questionnaire originally utilized in the PISAPED. The two samples differed significantly as regards age, proportion of
outpatients, prevalence of unprovoked PE, and of active cancer. Sudden onset dyspnea was the most frequent symptom in
both samples (81 and 78%), followed by chest pain (56 and 39%), fainting or syncope (26 and 22%), and hemoptysis (7 and
5%).Atleastoneof the abovesymptomswasreportedby756 (94%)of800patients.Isolated symptomsand signsofdeepvein
thrombosis occurred in 3% of the cases. Only 7 (1%) of 800 patients had no symptoms before PE was diagnosed.
Conclusions/Significance: Most patients with PE feature at least one of four symptoms which, in decreasing order of
frequency, are sudden onset dyspnea, chest pain, fainting (or syncope), and hemoptysis. The occurrence of such symptoms,
if not explained otherwise, should alert the clinicians to consider PE in differential diagnosis, and order the appropriate
objective test.
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Introduction
Pulmonary embolism (PE) is a common but still underdiagnosed
condition. In a survey of the relevant literature from 1945 through
2002, PE was unsuspected or undiagnosed ante-mortem in 3268
(84%) of 3876 patients who had PE discovered at autopsy [1].
Remarkably, even in the patients with large or fatal PE at autopsy,
the majority (1902 of 2448, or 78%) were never suspected of
having the disease during life [1].
It is maintained that PE may escape prompt diagnosis because
clinical symptoms and signs are nonspecific. Lack of specificity
could be a limitation if we were to diagnose PE on clinical grounds
only, but it has no bearing on the issue of raising the suspicion of
the disease. This depends very much on the clinician’s ability to
formulate a diagnostic hypothesis by taking into proper account a
number of clinical symptoms and signs. Raising the suspicion is the
crucial step in the diagnostic work-up of PE because it allows
selecting patients for further objective testing [2].
The present study was undertaken to assess the prevalence of
clinical symptoms, signs, and their combination in a large sample
of patients with PE from two different clinical settings. We focused
on the identification of the symptoms and signs that prompted the
patients to seek medical attention. We collected the relevant




The study protocol was approved by the ethics committee of the
Careggi University Hospital, Firenze (Italy). An informed written
consent was obtained from each patient prior to study entry.
Sample
The study included 800 patients with an established diagnosis of
PE. Three-hundred-sixty of them were evaluated consecutively at
the Unit of Atherothrombotic Disorders (UAD), Careggi Univer-
sity Hospital, Firenze (Italy), between January 1, 2009 and
December 31, 2010, for the following reasons:
(a) to search for inherited thrombophilia; (b) to plan the duration
of oral anticoagulant therapy; (c) to assess the extent of perfusion
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evaluate the right ventricular function by transthoracic echocar-
diography at the time of perfusion scintigraphy.
These patients had been diagnosed with and treated for acute
PE in seven hospitals of central Tuscany. They were referred to
the UAD within 4 weeks after hospital discharge.
The 440 other patients with PE were part of a sample of 1100
consecutive patients with suspected PE, who were enrolled in the
Prospective Investigative Study of Acute Pulmonary Embolism
Diagnosis (PISAPED) at the Institute of Clinical Physiology, Pisa
(Italy), between 1991 and 1999 [3–6].
Collection of clinical data
The 360 patients comprised in the Firenze sample were
examined by the authors at the outpatient clinic of the UAD.
Care was taken to identify risk factors for PE, and pre-existing
diseases which may mimic the clinical presentation of PE. Each
patient was invited to complete a self-administered standardized
questionnaire including the description of the symptoms experi-
enced, and the time interval between the onset of symptoms and
the diagnosis of PE (table 1). The questionnaire is in all similar to
that used in the PISAPED [3–6].
Every effort was made to retrieve from clinical files the
electrocardiograms (ECG) obtained on the day of PE diagnosis.
The ECGs were reviewed by a cardiologist who was blinded to the
diagnosis. Acute right ventricular (RV) overload was deemed
present if one or more of the following abnormalities were
identified: S-wave in lead I and Q-wave in lead III each of
amplitude .1.5 mm, with T-wave inversion in lead III (S1Q3T3),
S-waves in lead I, II, and III each of amplitude .1.5 mm (S1S2S3),
T-wave inversion in right precordial leads, transient right bundle
branch block, and pseudoinfarction [7–8].
The 440 patients with PE included in the PISAPED had been
examined by one of twelve chest physicians who took part in the
study. All the clinical and laboratory data were recorded by the
physicians on a standard form before any further objective testing
[3–6]. Data on the clinical presentation of PE were retrieved from
the PISAPED database, and used for comparison with the clinical
data acquired in the 360 other patients. The following paragraphs
refer to the procedures used for diagnosing PE, assessing perfusion
recovery and right ventricular function in the patients comprised
in the Firenze sample.
Diagnostic criteria for pulmonary embolism
PE diagnosis was established by multidetector computed
tomographic angiography (CTA), perfusion lung scintigraphy, or
ventilation-perfusion scintigraphy. Angiographic criteria included
the identification of an embolus obstructing a vessel or the outline
of an embolus within a vessel. Perfusion scans were considered
positive for PE if showing segmental (wedge-shaped) perfusion
defects [3]. Ventilation-perfusion scans were rated ‘‘high-proba-
bility’’ for PE if they featured segmental perfusion defects with
normal ventilation [9,10].
PE was classified as provoked if associated with known risk
factors such as recent trauma, bone fracture, major surgery,
pregnancy/post-partum, active cancer, use of oral contraceptives,
or immobilization for longer than 3 consecutive days. In all other
instances, it was considered unprovoked.
Assessment of residual perfusion defects by lung
scintigraphy
We estimated the extent of residual perfusion defects on the
lung scans obtained between 6 and 12 months of PE diagnosis.
Such estimation was carried out by a nuclear medicine specialist,
according to a method validated against pulmonary angiography
[11]. Briefly, each lobe is attributed a weight according to regional
blood flow as follows: right upper lobe, 0.18; right middle lobe,
0.12; right lower lobe, 0.25; left upper lobe, 0.13; lingula, 0.12; left
lower lobe, 0.20. The perfusion of each lobe is estimated visually
Table 1. Standardized questionnaire.
Please, answer the following questions concerning the symptoms you may
have had before the diagnosis of pulmonary embolism (PE) was established.
No symptoms at all
Yes
No
Dyspnea (shortness of breath) during exertion or at rest
Yes
No
If yes, how would you describe its onset?
Sudden (in a matter of hours)
Gradual (over a period of several days or weeks)







If yes, how would you describe it?
Precordial or substernal (as an oppression over the anterior chest wall)
Pleuritic (as a stabbing or shooting in the chest, exacerbated by breathing,
coughing, sneezing, or even talking)

















Time interval between onset of symptoms and diagnosis of PE
Within one day
More than one day (please, specify):
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‘‘not perfused’’ and 1 ‘‘normally perfused’’. Visual estimates of
perfusion are based on the combined evaluation of six scinti-
graphic views (anterior, posterior, both lateral, and both posterior
oblique). Each lobar perfusion score is obtained by multiplying the
weight assigned to the lobe by the estimated perfusion of that lobe.
The overall score is the sum of the perfusion scores of the six lobes,
and the percentage of pulmonary vascular obstruction is calculated
as: (1–overall perfusion score)6100.
Transthoracic echocardiography and chest radiography
Transthoracic echocardiography and postero-anterior and
lateral chest radiographs were obtained at the time of perfusion
lung scanning. Echocardiograms were performed and interpreted
by an experienced cardiologist. Measured variables included the
end-diastolic right ventricle diameter, the thickness of the right
ventricle free wall, and the tricuspid regurgitation velocity (if
measurable). The right ventricular wall motion was assessed
qualitatively. An end-diastolic right ventricle diameter ,26 mm, a
wall thickness ,7 mm, and a tricuspid regurgitation velocity
,2.7 m/s were regarded as normal [12].
Chest radiographs were examined by one of the authors (MM)
for the presence of dilatation of the pulmonary artery trunk, and of
the right ventricle that are suggestive of chronic thromboembolic
pulmonary hypertension (CTEPH) [13].
The patients who featured persistent, bilateral perfusion defects
in the lung scans taken between 6 and 12 months of PE diagnosis,
were re-evaluated by lung scintigraphy and transthoracic echo-
cardiography at 3-month intervals. If the lung scans remained
unchanged over time, and the echocardiograms and chest
radiographs were suggestive of CTEPH, right heart catheteriza-
tion and pulmonary angiograms were obtained. Diagnostic criteria
included a mean pulmonary artery pressure .25 mmHg with a
mean pulmonary occlusion pressure ,15 mmHg, and the
presence of multiple lobar, segmental, or subsegmental filling
defects on selective pulmonary angiography [14].
Statistical analysis
Differences between groups were assessed by Fisher’s exact test
for the categorical variables, and by Mood’s median test for the
continuous variables. Continuous variables in the text and in the
tables are reported as median and interquartile range (IQR).
Ninety-five confidence intervals (CI) were calculated according to
the binomial distribution with continuity correction. Two-tailed p-
values of less than 0.05 were considered statistically significant
throughout. The statistical analysis was performed with Stata
version 10 (StataCorp, College Station, TX).
Results
Patient characteristics
The baseline characteristics of the 440 patients with PE from
the PISAPED are given in detail elsewhere [3–6]. PE was
diagnosed by selective pulmonary angiography in 436 and by
autopsy in 4. They are used here for the purpose of comparing the
prevalence of clinical symptoms and signs with the 360 patients
comprised in the Firenze sample. In the latter group, most of the
subjects (90%) were outpatients at the time of PE diagnosis, and
nearly 70% had unprovoked PE (table 2). In most cases,
multidetector CTA was used as the diagnostic technique (table 2);
medical treatment consisted of unfractionated heparin or low
molecular weight heparins in 88% of the patients (table 2).
All the 360 patients completed the scintigraphy follow-up. By
one year of diagnosis, the median score of residual perfusion
defects was 0% (IQR, 0–10%). Five patients showed persistent,
bilateral perfusion defects consistent with chronic PE. Three of
them (0.8% of 360) met the hemodynamic criteria of CTEPH.
Such incidence is nearly the same as in the PISAPED [15].
Symptoms and signs (Firenze sample)
The prevalence of clinical symptoms and signs is reported in
table 3. They were in decreasing order of frequency: sudden onset
dyspnea, chest pain, unilateral painful swelling of the lower or
upper extremity, fainting or syncope, and hemoptysis. Very few
patients experienced gradual onset dyspnea, cough, or high fever,
and none complained of orthopnea. Chest pain was unilateral and
pleuritic in type in 118 (84%) of 140 patients. In 17 (94%) of the 18
cases who reported hemoptysis, the symptom was associated with
sudden onset dyspnea, chest pain, or both. The median interval
between symptoms’ onset and diagnosis of PE was 2 days (table 2).
Yet, in 25% of the patients, the time to diagnosis exceeded 7 days
(median time 20 days). Most of the patients in whom the diagnosis
of PE was delayed had sudden unexplained dyspnea as the initial
clinical symptom.
ECGs, obtained on the day of PE diagnosis, were made
available in 334 (93%) of 360 patients; signs of acute RV overload
were present in 139 of 334 (42%, IQR 36–47%).
Comparison between the two samples
As shown in table 4, the two samples differed significantly in
terms of age, proportion of outpatients at the time of PE diagnosis,
prevalence of unprovoked PE, and of active cancer. These
differences notwithstanding, the prevalence of symptoms and
signs was similar in the two samples. Chest pain prevailed
significantly in the PISAPED patients, whereas unilateral swelling
of the lower or upper extemity (taken as a sign of deep vein
Table 2. Baseline characteristics of 360 patients with
pulmonary embolism (Firenze sample).
Number or Median (Percent or IQR)
Baseline characteristics
Outpatients 324 (90)
Time to diagnosis, days 2 (1–7)
Age, years 61 (46–71)
Male sex 162 (45)
Unprovoked PE 237 (66)
Prior cardiovascular disease 86 (24)
Prior pulmonary disease 20 (6)
Active cancer 20 (6)
Diagnostic technique
MD-CTA 298 (83)
Perfusion lung scintigraphy 56 (15)
Ventilation-Perfusion scintigraphy 6 (2)
Therapy in the acute stage
Unfractionated heparin 227 (63)
Low molecular weight heparins 90 (25)
Fondaparinux 29 (8)
Thrombolysis 14 (4)
IQR=interquartile range. PE=pulmonary embolism. MD-CTA=multidetector
computed tomographic angiography.
doi:10.1371/journal.pone.0030891.t002
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in the Firenze sample.
The prevalence of ECG signs of acute RV overload was nearly
identical in the two samples (table 4). Considering the whole
sample, the patients with RV overload featured a significantly
higher prevalence of sudden onset dyspnea (87% vs 74%,
p,0.0001) and of syncope (35% vs 15%, p,0.0001), and a lower
prevalence of hemoptysis (3% vs 8%, p=0.004) than those
without RV overload.
Combination of clinical symptoms and signs in the two
samples
At least one of four symptoms (sudden onset dyspnea, chest
pain, fainting or syncope, and hemoptysis) were reported by 756
(94%) of 800 patients (table 5). Isolated symptoms and signs of
DVT occurred in 22 cases (3%). Twenty had proximal DVT of the
lower limb, and two had DVT of the upper limb extending to the
subclavian vein. The 22 patients with isolated manifestations of
DVT had a median age of 48 years (IQR, 38–60 years), and were
significantly younger (p,0.001) than the 778 other patients
(median age 66 years, IQR, 53–74 years).
Only 7 (1%) of 800 patients had no symptoms prior to the
diagnosis of PE (table 5). In one, PE was diagnosed incidentally
when he was referred unconscious to the radiology department
shortly after severe head trauma and multiple bone fractures. The
six other patients had minor PE affecting one or two lung
segments.
The combination of clinical symptoms and signs are reported
separately for the Pisa and Firenze sample in table 6.
Discussion
The present study was undertaken to reconsider the clinical
presentation of PE with special emphasis on the identification of
those symptoms and signs that prompt the patients to seek medical
attention. We addressed this issue by interviewing directly the
patients using a standardized form that was originally utilized in
the PISAPED [3–6]. In that study, the patients with suspected PE
were examined before they underwent the definitive test to
confirm or exclude the diagnosis. The patients included in the
Firenze sample could not be interviewed as timely as those in the
PISAPED. However, the occurrence of a recall bias seems very
unlikely because all of them were evaluated shortly after hospital
discharge.
In conformity with the strategy adopted in the PISAPED [3–
6,15], all the patients included in the Firenze sample underwent a
scintigraphic follow-up to assess the extent of residual perfusion
abnormalities between 6 and 12 months of PE diagnosis. Virtually
all of them (99%) showed a complete or nearly complete
restoration of pulmonary perfusion. So, it seems reasonable to
assume that they had had a first episode of acute PE.
The two samples reported on here differ from each other as
regards age, proportion of inpatients, prevalence of unprovoked
PE and of active cancer. Yet, the prevalence of the reported
symptoms and signs is very similar. Sudden unexplained dyspnea
was by far the most frequent symptom in both samples, followed
by chest pain (usually pleuritic), fainting (or true syncope), and
hemoptysis. At least one of the above symptoms was reported by
94% of the patients in the whole sample.
In the PISAPED [5], the prevalence of sudden onset dyspnea,
chest pain, fainting (or true syncope), and hemoptysis was
significantly higher among the 440 patients with PE than in the
660 in whom the diagnosis was excluded (figure 1). Similarly,
clinical symptoms and signs suggestive of DVT prevailed
significantly in the patients with PE, and so did ECG signs of
acute right ventricle overload (figure 1). By contrast, gradual onset
dyspnea, orthopnea, and high fever prevailed significantly in the
patients in whom PE was ruled out (figure 1). At least one of four
symptoms (sudden onset dyspnea, chest pain, fainting/syncope,
and hemoptysis) was present in 97% of the 440 patients with PE
and in 62% of the 660 without PE (p,0.00001).
Table 3. Prevalence of symptoms and signs in 360 patients
with pulmonary embolism (Firenze sample).
Symptoms or signs Number (%) (95% CI)
Sudden onset dyspnea 281 (78) (74–82)
Gradual onset dyspnea 9 (3) (1–5)
Orthopnea 0 (0) (0–1)
Chest pain 140 (39) (34–44)
Fainting or syncope 78 (22) (18–26)
Hemoptysis 18 (5) (3–8)
Cough 14 (4) (2–7)
Unilateral painful swelling of lower or
upper extremity
137 (38) (33–43)
Fever .38uC 15 (4) (2–7)
CI=confidence interval.
doi:10.1371/journal.pone.0030891.t003
Table 4. Baseline characteristics and prevalence of clinical








%%%P - V a l u e *
Outpatients 52 21 90 ,0.001
Age .65 years{ 50 58 39 ,0.001
Male sex 46 47 45 0.669
Unprovoked PE 51 38 66 ,0.001
Active cancer 11 16 6 ,0.001
Prior cardiovascular diseases 27 29 24 0.108
Prior pulmonary diseases 7 8 6 0.129
Sudden onset dyspnea 80 81 78 0.251
Gradual onset dyspnea 3 3 3 0.673
Orthopnea 0.4 0.7 0 0.257
Chest pain 49 56 39 ,0.001
Fainting or syncope 24 26 22 0.183
Hemoptysis 6 7 5 0.240
Unilateral painful swelling of
lower or upper extremity
30 23 38 ,0.001
Fever .38uC 5 6 4 0.208
Acute RV overload (ECG) 44 45 42{ 0.306
Data are reported as percent of total in each sample.
RV=right ventricle. ECG=electrocardiogram.
*Pisa versus Firenze.
{Median age in the whole sample of 800 patients.
{In 139 of 334 patients in whom ECGs were available.
doi:10.1371/journal.pone.0030891.t004
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complained of orthopnea. This is at variance with the 36%
prevalence of orthopnea reported by Stein et al. in 192 patients
with PE enrolled in the PIOPED II [16]. Such remarkable
difference is likely the consequence of the criteria used in the two
studies to define orthopnea. In the PIOPED II, orthopnea is
considered present if the patient is used to lie on two or more
pillows, whereas in our study orthopnea is defined as a spell of
acute dyspnea (usually, but not necessarily, nocturnal) that forces
the patient to assume the seated or semirecumbent position. We
preferred such definition because the habit of lying on two or more
pillows at night is not unique to left heart failure with pulmonary
edema as it may be encountered in chronic obstructive lung
disease, asthma, obstructive sleep apnea, and gastro-esophageal
reflux.
The prevalence of symptoms and signs suggestive of DVT was
significantly higher in the Firenze sample than in the PISAPED. In
the latter, however, some 20% of the patients had undergone
major abdominal or pelvic surgery before the diagnosis of PE [3–
6]. So, in these patients, pulmonary emboli may have originated
from sites other than the deep veins of the lower limb.
Three percent of the patients presented with symptoms and
signs of DVT only. All of them had proximal DVT of the lower or
upper extremity, and had PE discovered at pulmonary angiogra-
phy. Reportedly, about one third of the patients with DVT have
‘‘silent’’ PE, the incidence of the disease being higher with
proximal than with distal DVT [17].
Therefore, routine screening for PE seems warranted in the
patients with DVT, particularly in those with proximal DVT [17].
Documenting PE in a patient with DVT may justify a more
aggressive in-hospital treatment because the short-term survival in
patientswith PEismuchworsethatinthose with isolated DVT [18].
In our study, 44% of 800 patients with PE had ECG signs of
acute RV overload. The occurrence of such abnormalities may
strengthen the suspicion of PE in a patient with unexplained
abrupt dyspnea, syncope, or chest pain.
We acknowledge that our study has a limitation: it deals with
patients in whom the diagnosis of PE was eventually established
during life. We can say nothing of those in whom PE was
undetected, and who may have died of it. This proportion will
probably remain unknown because the rate of autopsies drastically
declined over the last 20 years [19]. However, PE is rarely an all-
or-none disorder, so it can be timely suspected if due attention is
paid to the patient’s complaints. In 1967, Felix Fleischner wrote:
‘‘…before the acute massive attack, which may prove fatal, there
are often telltale warnings that may alert the clinicians to the
occurence of minor embolic events’’ [13]. Our findings are in
agreement with this statement.
Raising the suspicion of PE is instrumental to select patients in
whom objective testing is needed to confirm or exclude the
diagnosis.
Multidetector CTA is now regarded as the first-line imaging
technique for suspected PE as it permits the direct visualization of clots
in the pulmonary circulation. CT has revolutionized the practice of
medicine, particularly in the emergency departments (ED). In a
nationwide survey in the United States, the use of CT in the ED rose
from 2.7 million in 1995 to 16.2 million in 2007, corresponding to a
5.9-fold increase and an annual growth rate of 16% [20].
Mamlouk el al. evaluated retrospectively the medical records of
2003 consecutive patients (mean age 50 years, inpatients 49%,
female 58%) who underwent CTA for possible PE over a 1.5-year
period [21]. Inpatients were twice as likely to have PE as those
from the ED. Yet, the overall prevalence of PE was of only 9.8%
(197/2003). Notably, the occurrence of a positive angiogram in
the patients with no risk factors for PE was as low as 1% (5/520).
It seems, therefore, that CTA is increasingly used as a screening
method rather than a means to confirm or exclude clinically
Table 5. Combination of clinical symptoms and signs in 800
patients with pulmonary embolism.
Number (%) (95% CI)
Only one of four symptoms* 337 (42) (39–46)
Any two of four symptoms* 329 (41) (38–45)
Any three of four symptoms* 90 (11) (9–14)
At least one of four symptoms* 756 (94) (93–96)
Other symptoms{ 15 (2) (1–3)
Symptoms and signs of DVT only 22 (3) (2–4)
No symptoms at all 7 (1) (0.4–2)
CI=confidence intervals. DVT=deep vein thrombosis.
*Sudden onset dyspnea, chest pain, fainting or syncope, and hemoptysis. These
symptoms are not explained otherwise.
{Gradual onset dyspnea (n=10); palpitations (n=5).
doi:10.1371/journal.pone.0030891.t005
Table 6. Combination of clinical symptoms and signs in 800 patients with pulmonary embolism (Pisa versus Firenze).
Pisa (N=440) Firenze (N=360)
n (%) n (%) P-Value*
Only one of four symptoms{ 166 (38) 171 (47) 0.006
Any two of four symptoms{ 204 (46) 125 (35) ,0.001
Any three of four symptoms{ 58 (13) 32 (9) 0.057
At least one of four symptoms{ 428 (97) 328 (91) ,0.001
Other symptoms{ 8 (2) 7 (2) 1.000
Symptoms and signs of DVT only 1 (0.3) 21 (6) ,0.001
No symptoms at all 3 (0.7) 4 (1) 0.707
DVT=deep vein thrombosis.
*Pisa versus Firenze.
{Sudden onset dyspnea, chest pain, fainting or syncope, and hemoptysis. These symptoms are not explained otherwise.
{Gradual onset dyspnea (n=10); palpitations (n=5).
doi:10.1371/journal.pone.0030891.t006
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diagnostic procedures, and to expose the patients to an undue
amount of radiation. The latter is of concern, especially in women
of childbearing age. In fact, using a contemporary 64-detector
CTA protocol for PE, the absorbed dose to the female breast is the
range of 3.5 to 4.2 cGy [23], which is 30 times as great as that
absorbed during ventilation-perfusion scintigraphy (0.08 cGy) [9].
In summary, we found that the most reliable indicator of
patients with PE is sudden onset dyspnea. Other symptoms include
chest pain, fainting (or syncope), and hemoptysis. The occurrence
of such symptoms, if not explained otherwise, should alert the
clinicians to consider PE in differential diagnosis. This is the
crucial step in the diagnostic work-up of PE. Next, the clinical
probability should be assessed, ideally by means of a validated
prediction model [4–6,24]. If the clinical probability is low (20%
or less), the most practical approach would be to measure the D-
dimer concentration by a quantitative assay. If the D-dimer test is
negative, PE can be safely ruled out; if positive, additional
investigation is required [10]. Should the clinical probability of PE
be other than low, it would be sound to order immediately an
appropriate imaging technique (multidetector CTA, or lung
scintigraphy) to confirm or exclude the diagnosis [10].
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